Scotiabank Has Positive Forecast for Exelon FY2026 Earnings

Exelon logo with Utilities background
Image from MarketBeat Media, LLC.

Key Points

  • Scotiabank raised its FY2026 EPS forecast for Exelon to $2.89 from $2.85, while maintaining a Sector Perform rating and a $44 price target. The broader analyst consensus is $2.86 per share.
  • Exelon reported quarterly EPS of $0.87, topping the $0.79 consensus, and revenue of $7.32 billion versus estimates of $6.76 billion; revenue rose 9.2% year over year.
  • Analyst sentiment is mostly neutral: 14 analysts rate the stock Hold, five rate it Buy and one rates it Sell, with a consensus price target of $48.33. Exelon also declared a quarterly dividend of $0.42 per share, equivalent to a 3.6% yield.
  • Five stocks we like better than Exelon.

Exelon Corporation (NASDAQ:EXC - Free Report) - Stock analysts at Scotiabank lifted their FY2026 earnings per share (EPS) estimates for shares of Exelon in a research note issued on Monday, November 2nd. Scotiabank analyst A. Weisel now anticipates that the company will post earnings per share of $2.89 for the year, up from their prior forecast of $2.85. Scotiabank currently has a "Sector Perform" rating and a $44.00 price target on the stock. The consensus estimate for Exelon's current full-year earnings is $2.86 per share.

Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.87 EPS for the quarter, beating analysts' consensus estimates of $0.79 by $0.08. Exelon had a net margin of 10.17% and a return on equity of 9.75%. The business had revenue of $7.32 billion during the quarter, compared to analyst estimates of $6.76 billion. During the same quarter in the previous year, the business posted $0.86 EPS. Exelon's quarterly revenue was up 9.2% on a year-over-year basis.

Several other research firms also recently commented on EXC. HSBC assumed coverage on shares of Exelon in a research report on Thursday, October 22nd. They set a "hold" rating and a $44.00 target price for the company. Jefferies Financial Group reaffirmed a "hold" rating on shares of Exelon in a research report on Wednesday, October 28th. Argus cut their price target on Exelon from $52.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, September 22nd. JPMorgan Chase & Co. decreased their price objective on Exelon from $47.00 to $46.00 and set a "neutral" rating for the company in a report on Monday, October 19th. Finally, Weiss Ratings reissued a "buy (b-)" rating on shares of Exelon in a research note on Tuesday, October 6th. Five analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $48.33.

Check Out Our Latest Analysis on Exelon

Exelon Stock Up 1.6%

Exelon stock opened at $46.24 on Thursday. The firm has a market capitalization of $47.85 billion, a price-to-earnings ratio of 17.99, a price-to-earnings-growth ratio of 2.49 and a beta of 0.24. The firm's fifty day moving average price is $42.97 and its two-hundred day moving average price is $45.61. Exelon has a 1-year low of $39.73 and a 1-year high of $50.65. The company has a current ratio of 1.03, a quick ratio of 0.93 and a debt-to-equity ratio of 1.70.

Exelon Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Friday, December 4th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend is Friday, December 4th. Exelon's payout ratio is currently 65.37%.

Institutional Trading of Exelon

Several institutional investors and hedge funds have recently made changes to their positions in EXC. Searle & CO. purchased a new stake in shares of Exelon in the third quarter worth about $342,000. Csenge Advisory Group boosted its position in shares of Exelon by 6.6% in the third quarter. Csenge Advisory Group now owns 8,779 shares of the company's stock valued at $355,000 after acquiring an additional 544 shares during the period. New York Life Investment Management LLC grew its stake in Exelon by 0.9% during the third quarter. New York Life Investment Management LLC now owns 153,950 shares of the company's stock valued at $6,220,000 after acquiring an additional 1,306 shares in the last quarter. Texas Bank & Trust Co increased its holdings in Exelon by 1.9% during the 3rd quarter. Texas Bank & Trust Co now owns 15,733 shares of the company's stock worth $636,000 after acquiring an additional 286 shares during the period. Finally, M&G PLC increased its holdings in Exelon by 3.4% during the 3rd quarter. M&G PLC now owns 1,880,664 shares of the company's stock worth $75,227,000 after acquiring an additional 62,196 shares during the period. Hedge funds and other institutional investors own 80.92% of the company's stock.

Exelon Company Profile

(Get Free Report)

Exelon Corporation NASDAQ: EXC is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.

Exelon's utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.

Read More

Earnings History and Estimates for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines